Pioneer Trust Bank N A OR Has $7.94 Million Position in Danaher Co. (NYSE:DHR)

Pioneer Trust Bank N A OR boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 4.1% during the fourth quarter, Holdings Channel reports. The institutional investor owned 34,340 shares of the conglomerate’s stock after acquiring an additional 1,355 shares during the quarter. Danaher comprises about 2.4% of Pioneer Trust Bank N A OR’s investment portfolio, making the stock its 16th biggest position. Pioneer Trust Bank N A OR’s holdings in Danaher were worth $7,944,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in DHR. BKM Wealth Management LLC bought a new position in shares of Danaher in the fourth quarter valued at about $27,000. Wetzel Investment Advisors Inc. bought a new stake in Danaher during the 4th quarter worth approximately $29,000. OFI Invest Asset Management bought a new stake in Danaher during the 3rd quarter worth approximately $30,000. Rakuten Securities Inc. bought a new stake in Danaher during the 4th quarter worth approximately $36,000. Finally, Financial Connections Group Inc. bought a new stake in Danaher during the 4th quarter worth approximately $41,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of a number of research reports. Raymond James increased their target price on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Barclays raised their price target on shares of Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Wednesday, April 24th. Robert W. Baird raised their price target on shares of Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 24th. Royal Bank of Canada raised their price target on shares of Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Finally, KeyCorp raised their target price on shares of Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a research note on Thursday, February 1st. Six research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $267.31.

Danaher Stock Performance

Danaher stock traded up $1.88 during trading on Thursday, reaching $251.43. The company had a trading volume of 1,505,798 shares, compared to its average volume of 2,712,004. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $259.00. The firm’s 50-day simple moving average is $248.27 and its 200 day simple moving average is $233.19. The firm has a market capitalization of $186.23 billion, a price-to-earnings ratio of 42.51, a price-to-earnings-growth ratio of 3.82 and a beta of 0.83. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The business’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same period in the previous year, the company earned $2.36 earnings per share. Sell-side analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, June 28th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. Danaher’s payout ratio is currently 18.31%.

Insider Activity

In other news, Director Walter G. Lohr sold 3,289 shares of Danaher stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $251.15, for a total transaction of $826,032.35. Following the sale, the director now owns 14,129 shares of the company’s stock, valued at approximately $3,548,498.35. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Danaher news, Director Walter G. Lohr sold 3,289 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $251.15, for a total value of $826,032.35. Following the sale, the director now owns 14,129 shares of the company’s stock, valued at $3,548,498.35. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Georgeann Couchara sold 2,622 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total value of $636,280.74. Following the completion of the sale, the senior vice president now directly owns 4,244 shares in the company, valued at approximately $1,029,891.48. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 103,984 shares of company stock valued at $25,997,094. 10.90% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.